Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141,798 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgETrap-Fc protein in subjects with Atopy: Results from the First-in-Human study.
Ye YM, Park JW, Kim SH, Cho YS, Lee SY, Lee SY, Sim S, Song E, Kim B, Lee J, Kim SK, Jang MH, Park HS. Ye YM, et al. Among authors: lee sy, lee j. Int Immunopharmacol. 2024 Mar 30;130:111706. doi: 10.1016/j.intimp.2024.111706. Epub 2024 Feb 20. Int Immunopharmacol. 2024. PMID: 38382265 Free article. Clinical Trial.
Safety, tolerability and pharmacokinetics and pharmacodynamics of HL2351, a novel hybrid fc-fused interleukin-1 receptor antagonist, in healthy subjects: A first-in-human study.
Oh J, Huh KY, Cho YG, Cha JE, Kim SJ, Yoon SH, Park SS, Yoon H, Lee J, Lee H. Oh J, et al. Among authors: lee h, lee j. Br J Clin Pharmacol. 2020 Feb;86(2):372-379. doi: 10.1111/bcp.14161. Epub 2020 Jan 3. Br J Clin Pharmacol. 2020. PMID: 31658396 Free PMC article. Clinical Trial.
141,798 results
You have reached the last available page of results. Please see the User Guide for more information.